Skip to main content
Watch Insiders
PCSA filings

Corporate insider profile

George K Ng Filing Activity

Latest reported as Chief Executive Officer of Processa Pharmaceuticals, Inc. (PCSA).

Purchase filings
5
Reported companies
1
Net open-market value
$27,363
Latest transaction
Jun 15, 2026

Affiliated corporations

Reported company relationships

PCSALatest reported

Processa Pharmaceuticals, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Executive OfficerOpen Market Purchase2,465$2.22$5,472
May 29, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Executive OfficerOpen Market Purchase2,129$2.57$5,472
May 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Executive OfficerOpen Market Purchase1,843$2.97$5,474
Subscribe to see more data